한글목차

개요

HTS(High Throughput Screening) 시장은 2023년부터 2028년까지 199억 달러로 예측되며, 예측 기간 동안 12.12%의 CAGR을 기록할 것으로 예상됩니다.

본 보고서는 HTS(High Throughput Screening) 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 R&D 투자 증가, 만성 질환의 유병률 증가, 의약품 특허 만료 등이 시장을 주도하고 있습니다.

이 보고서는 향후 몇 년 동안 HTS(High Throughput Screening) 시장의 성장을 촉진하는 주요 요인 중 하나로 판촉 활동에 대한 관심이 높아지는 것을 꼽았습니다. 또한, 아웃소싱 활동의 성장과 하이스루풋 스크리닝 서비스의 기술 발전은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계

제3장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• HTS(High Throughput Screening) 세계 시장 2018-2022
• 용도별 부문 분석 2018-2022
• 최종사용자 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 타겟 특정과 검증 : 시장 규모와 예측 2023-2028
• 1차 심사, 2차 심사 : 시장 규모와 예측 2023-2028
• 독성 평가 : 시장 규모와 예측 2023-2028
• 줄기세포 조사 : 시장 규모와 예측 2023-2028
• 시장 기회 : 용도별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 제약회사 및 바이오테크놀러지 회사 : 시장 규모와 예측 2023-2028
• 학술연구기관 : 시장 규모와 예측 2023-2028
• CRO : 시장 규모와 예측 2023-2028
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 프랑스 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 상황

• 개요
• 벤더 상황
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Agilent Technologies Inc.
• Aurora Biomed Inc.
• Axxam Spa
• Beckman Coulter Inc.
• Bio Rad Laboratories Inc.
• Charles River Laboratories International Inc.
• Corning Inc.
• Danaher Corp.
• Lonza Group Ltd.
• Merck KGaA
• NanoTemper Technologies GmbH
• PerkinElmer Inc.
• Sygnature Discovery Ltd.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

제13장 부록

영문목차

Abstract

The high throughput screening (HTS) market is forecasted to grow by USD 19.9 bn during 2023-2028, accelerating at a CAGR of 12.12% during the forecast period. The report on the high throughput screening (HTS) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in R and D investments, increasing prevalence of chronic diseases, and patent expiration of drugs.

Technavio's high throughput screening (HTS) market is segmented as below:

By Application

• Target identification and validation
• Primary and secondary screening
• Toxicology assessment
• Stem cell research

By End-user

• Pharmaceutical and biotechnology companies
• Academic and research institutes
• CROs

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing focus on promotional activities as one of the prime reasons driving the high throughput screening (HTS) market growth during the next few years. Also, growth in outsourcing activities and technological advances in the high throughput screening services will lead to sizable demand in the market.

The report on the high throughput screening (HTS) market covers the following areas:

• High throughput screening (HTS) market sizing
• High throughput screening (HTS) market forecast
• High throughput screening (HTS) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading high throughput screening (HTS) market vendors that include Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the high throughput screening (HTS) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global high throughput screening (HTS) market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global high throughput screening (hts) market 2018 - 2022 ($ billion)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Target identification and validation - Market size and forecast 2023-2028
• Exhibit 34: Chart on Target identification and validation - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Target identification and validation - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Target identification and validation - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Target identification and validation - Year-over-year growth 2023-2028 (%)
• 6.4 Primary and secondary screening - Market size and forecast 2023-2028
• Exhibit 38: Chart on Primary and secondary screening - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Primary and secondary screening - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Primary and secondary screening - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Primary and secondary screening - Year-over-year growth 2023-2028 (%)
• 6.5 Toxicology assessment - Market size and forecast 2023-2028
• Exhibit 42: Chart on Toxicology assessment - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Toxicology assessment - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Toxicology assessment - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Toxicology assessment - Year-over-year growth 2023-2028 (%)
• 6.6 Stem cell research - Market size and forecast 2023-2028
• Exhibit 46: Chart on Stem cell research - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Stem cell research - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Stem cell research - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Stem cell research - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Application
• Exhibit 50: Market opportunity by Application ($ billion)
• Exhibit 51: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 54: Chart on Comparison by End-user
• Exhibit 55: Data Table on Comparison by End-user
• 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• Exhibit 56: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• 7.4 Academic and research institutes - Market size and forecast 2023-2028
• Exhibit 60: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• 7.5 CROs - Market size and forecast 2023-2028
• Exhibit 64: Chart on CROs - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on CROs - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on CROs - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on CROs - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 68: Market opportunity by End-user ($ billion)
• Exhibit 69: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
• Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 Agilent Technologies Inc.
• Exhibit 119: Agilent Technologies Inc. - Overview
• Exhibit 120: Agilent Technologies Inc. - Business segments
• Exhibit 121: Agilent Technologies Inc. - Key offerings
• Exhibit 122: Agilent Technologies Inc. - Segment focus
• 12.4 Aurora Biomed Inc.
• Exhibit 123: Aurora Biomed Inc. - Overview
• Exhibit 124: Aurora Biomed Inc. - Product / Service
• Exhibit 125: Aurora Biomed Inc. - Key offerings
• 12.5 Axxam Spa
• Exhibit 126: Axxam Spa - Overview
• Exhibit 127: Axxam Spa - Product / Service
• Exhibit 128: Axxam Spa - Key offerings
• 12.6 Beckman Coulter Inc.
• Exhibit 129: Beckman Coulter Inc. - Overview
• Exhibit 130: Beckman Coulter Inc. - Product / Service
• Exhibit 131: Beckman Coulter Inc. - Key offerings
• 12.7 Bio Rad Laboratories Inc.
• Exhibit 132: Bio Rad Laboratories Inc. - Overview
• Exhibit 133: Bio Rad Laboratories Inc. - Business segments
• Exhibit 134: Bio Rad Laboratories Inc. - Key news
• Exhibit 135: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 136: Bio Rad Laboratories Inc. - Segment focus
• 12.8 Charles River Laboratories International Inc.
• Exhibit 137: Charles River Laboratories International Inc. - Overview
• Exhibit 138: Charles River Laboratories International Inc. - Business segments
• Exhibit 139: Charles River Laboratories International Inc. - Key news
• Exhibit 140: Charles River Laboratories International Inc. - Key offerings
• Exhibit 141: Charles River Laboratories International Inc. - Segment focus
• 12.9 Corning Inc.
• Exhibit 142: Corning Inc. - Overview
• Exhibit 143: Corning Inc. - Business segments
• Exhibit 144: Corning Inc. - Key news
• Exhibit 145: Corning Inc. - Key offerings
• Exhibit 146: Corning Inc. - Segment focus
• 12.10 Danaher Corp.
• Exhibit 147: Danaher Corp. - Overview
• Exhibit 148: Danaher Corp. - Business segments
• Exhibit 149: Danaher Corp. - Key news
• Exhibit 150: Danaher Corp. - Key offerings
• Exhibit 151: Danaher Corp. - Segment focus
• 12.11 Lonza Group Ltd.
• Exhibit 152: Lonza Group Ltd. - Overview
• Exhibit 153: Lonza Group Ltd. - Business segments
• Exhibit 154: Lonza Group Ltd. - Key news
• Exhibit 155: Lonza Group Ltd. - Key offerings
• Exhibit 156: Lonza Group Ltd. - Segment focus
• 12.12 Merck KGaA
• Exhibit 157: Merck KGaA - Overview
• Exhibit 158: Merck KGaA - Business segments
• Exhibit 159: Merck KGaA - Key news
• Exhibit 160: Merck KGaA - Key offerings
• Exhibit 161: Merck KGaA - Segment focus
• 12.13 NanoTemper Technologies GmbH
• Exhibit 162: NanoTemper Technologies GmbH - Overview
• Exhibit 163: NanoTemper Technologies GmbH - Product / Service
• Exhibit 164: NanoTemper Technologies GmbH - Key offerings
• 12.14 PerkinElmer Inc.
• Exhibit 165: PerkinElmer Inc. - Overview
• Exhibit 166: PerkinElmer Inc. - Business segments
• Exhibit 167: PerkinElmer Inc. - Key news
• Exhibit 168: PerkinElmer Inc. - Key offerings
• Exhibit 169: PerkinElmer Inc. - Segment focus
• 12.15 Sygnature Discovery Ltd.
• Exhibit 170: Sygnature Discovery Ltd. - Overview
• Exhibit 171: Sygnature Discovery Ltd. - Product / Service
• Exhibit 172: Sygnature Discovery Ltd. - Key offerings
• 12.16 Tecan Trading AG
• Exhibit 173: Tecan Trading AG - Overview
• Exhibit 174: Tecan Trading AG - Business segments
• Exhibit 175: Tecan Trading AG - Key offerings
• Exhibit 176: Tecan Trading AG - Segment focus
• 12.17 Thermo Fisher Scientific Inc.
• Exhibit 177: Thermo Fisher Scientific Inc. - Overview
• Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 179: Thermo Fisher Scientific Inc. - Key news
• Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 182: Inclusions checklist
• Exhibit 183: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 184: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 185: Research methodology
• Exhibit 186: Validation techniques employed for market sizing
• Exhibit 187: Information sources
• 13.5 List of abbreviations
• Exhibit 188: List of abbreviations